Inflammatory Brain Disorders Conference 2026

The Inflammatory Brain Disorders Conference 2026 is a virtual event focusing on the latest clinical and research advances in inflammatory brain disorders. Hosted by the Neuroimmune Institute, the conference features renowned experts presenting on diagnostic and therapeutic approaches. Attendees will gain insights into emerging clinical and research challenges, with presentations selected to familiarize them with rapidly developing research and treatment options. The conference is valuable for both generalists and specialists in pediatric and adult medicine, including pediatricians, family physicians, psychiatrists, rheumatologists, immunologists, neurologists, and infectious disease physicians. The agenda includes a range of topics such as neuroimmunology, PANS/PANDAS, and neuropsychiatry, with a focus on clinical applications and research advancements. The event offers 12.0 AMA PRA Category 1 Credits™ and is designed to educate clinicians on the latest understanding of treatment options.

Neuroimmune Institute

The Neuroimmune Institute is dedicated to educating and advancing research on neuroimmune, immunopsychiatric, and inflammatory brain conditions.

Email: conference@neuroimmuneinstitute.org

Phone: 904-599-8464

Cost	Type	Notes
$499.00	Non-member early bird	Early bird registration for non-members.
$349.00	Professional early bird	Early bird registration for Clinician Impact Circle Members.
$149.00	Community early bird	Early bird registration for Patients/Families Impact Circle Members.
$899.00	Full price	Full price for live virtual attendance without recordings.

See the conference's actual website for more details around these fees, as sometimes they can be more complicated.

The conference will be held from 8:00 am to 4:30 pm PT each day. The full agenda will be available from March/April 2026.

Susanne Bejerot, MD, PhD

Professor of Psychiatry, Örebro University, School of Medical Sciences.

Kevin J. Tracey, MD

President and CEO, Feinstein Institutes for Medical Research; Professor, Institute of Bioelectronic Medicine.

Terrence Thomas, MD, MMed (Paed), MRCPCH

Paediatric Neurologist and Head, Neurology Service, KK Women’s and Children’s Hospital, Singapore.

Alessandro Colasanti, MD, PhD

Associate Professor in Biological Psychiatry, Brighton and Sussex Medical School.

Rajat Gupta, MBChB, FRCPCH

Consultant Paediatric Neurologist, Birmingham Children’s Hospital.

Terry Harville, MD, PhD

Professor of Pathology and Laboratory Services, University of Arkansas for Medical Sciences.

Lauren Breithaupt Langston, PhD

Assistant Professor of Psychology, Massachusetts General Hospital.

Steven A. Kushner, MD, PhD

Professor, Department of Psychiatry, Columbia University.

Joshua Ryan Smith, MD

Director, Division of Child and Adolescent Psychiatry, Vanderbilt University Medical Center.

Livia De Picker, MD, PhD

Assistant Professor of Clinical Immunopsychiatry, University of Antwerp, Belgium.

Ryan Kammeyer, MD

Assistant Professor of Pediatrics and Neurology, Children’s Hospital Colorado.

Ahmed Obeidat, MD, PhD

Associate Professor, The Medical College of Wisconsin.

Christopher Bartley, MD, PhD

Chief of the Translational Immunopsychiatry Unit, NIMH, NIH.

Jennifer Frankovich, MD

Clinical Professor of Pediatrics, Stanford University School of Medicine.

John Pluvinage, MD, PhD

Physician-Scientist, Department of Neurology, UCSF.

John Gaitanis, MD

Associate Professor of Pediatrics, Brown University School of Medicine.

The conference offers a maximum of 12.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Sponsorship opportunities are available. Interested parties can email conference@neuroimmuneinstitute.org for details.